Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated

• US 6,928,320 B2
• Filed: 05/17/2001
• Issued: 08/09/2005
• Est. Priority Date: 05/17/2001
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: King, Gary W.
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US09/859,280
• Publication Number:
  US 20040162594A1
• Time in Patent Office: 1,545 Days
• Field of Search: 607/4, 607/5, 607/46, 607/63, 607/2, 607/68, 607/69
• US Class Current: 607/5
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/36071 Pain
• CPC Class Codes: A61N 1/39624 Pain reduction therapy

Abstract

A desired effect is produced by therapeutically activating tissue at a first site within a patient'"'"'s body and a corresponding undesired side effect is reduced by blocking activation of tissue or conduction of action potentials at a second site within the patient'"'"'s body by applying high frequency stimulation and/or direct current pulses at or near the second site. Time-varying DC pulses may be used before or after a high frequency blocking signal. The high frequency stimulation may begin before and continue during the therapeutic activation. The high frequency stimulation may begin with a relatively low amplitude, and the amplitude may be gradually increased. The desired effect may be promotion of micturition or defecation and the undesired side effect may be sphincter contraction. The desired effect may be defibrillation of the patient'"'"'s atria or defibrillation of the patient'"'"'s ventricles, and the undesired side effect may be pain.

Claims

1. A system for producing a desired effect by therapeutically activating tissue at a first predetermined site within a patient'"'"'s body and for reducing a corresponding undesired side effect by blocking activation of tissue or conduction of action potentials at a second predetermined site within the patient'"'"'s body, the system comprising:

a first signal generator for producing low frequency stimulation;

a second signal generator for producing high frequency and/or direct current pulse stimulation;

at least one implantable load including a first electrode coupled to the first signal generator, the first electrode being adapted to therapeutically activate tissue at the first predetermined site by applying low frequency stimulation, the at least one implantable lead including a second electrode coupled to the second signal generator, the second electrode being adapted to block activation of electrically excitable tissue at the second site by applying high frequency stimulation or one or more direct current pulses or both high frequency stimulation and one or more direct current pulses at or near the second site;

wherein the desired effect is selected from the group consisting of;

defibrillation of the patient'"'"'s atria or defibrillation of the patient'"'"'s ventricles, and the undesired side effect is pain; and

wherein the high frequency stimulation or the direct current pulses or both the high frequency stimulation and the direct current pulses begin before and continue during the therapeutic activation, begin with a relatively low amplitude that is gradually increased, and are terminated by gradually reducing the amplitude of the high frequency stimulation or the direct current pulses or both the high frequency stimulation and the direct current pulses.

2. The system of claim 1, wherein:

the first site is selected from the group consisting of;

inside the patient'"'"'s heart chambers and outside the patient'"'"'s heart chambers.

3. The system of claim 1, wherein:

the second site is selected from the group consisting of the patient'"'"'s;

vagus nerve, branches of the patient'"'"'s vagus nerve from the patient'"'"'s heart, thoracic sympathetic nerves, ansa subclavia, sympathetic trunk ganglia (T1-T4), stellate ganglia, cervical ganglia (C1-C8), celiac plexus, brachial plexi, dorsal roots (C1-T4), spinal dorsal columns, and dorsal roots.

4. The system of claim 1, further comprising:

a sensor for sensing a state of the tissue at the second site or at a site that is remote from both the first site and the second site; and

means, responsive to the sensor, for adjusting at least one parameter of the high frequency stimulation or the direct current pulses or both the high frequency stimulation and the direct current pulses, the parameter being selected from the group consisting of;

pulse amplitude, pulse width, pulse frequency, pulse duty cycle, pulse polarity, and pulse waveform.

5. The system of claim 1, further comprising:

a sensor for sensing a state of the tissue at the second site or at a site that is remote from both the first site and the second site; and

means, responsive to an indication from the sensor that tissue at the second site or at the remote site is activated, for applying the high frequency stimulation or the direct current pulses or both the high frequency stimulation and the direct current pulses to the second site.